Format

Send to

Choose Destination
See comment in PubMed Commons below
Med Sci Monit. 2014 Jun 10;20:953-9. doi: 10.12659/MSM.890496.

Clinical application of adoptive T cell therapy in solid tumors.

Author information

1
Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China (mainland).

Abstract

As an emerging therapeutic approach, adoptive T cell therapy shown promise in advanced solid malignancies. The results obtained in patients with metastatic melanoma and kidney cancer are encouraging because of the visible clinical benefits and limited adverse effects. Recently, the genetically-modified T cells expressing specific T cell receptors or chimeric antigen receptors are just now entering the clinical arena and show great potential for high avidity to tumor-associated antigens and long-lasting anti-tumor responses. However, continued investigations are necessary to improve the cell product quality so as to decrease adverse effects and clinical costs, and make adoptive T cell therapy a tool of choice for solid malignancies.

PMID:
24912947
PMCID:
PMC4063985
DOI:
10.12659/MSM.890496
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for International Scientific Literature, Ltd. Icon for PubMed Central
    Loading ...
    Support Center